Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Helena Masanas"'
Autor:
Rubén Olivera-Salguero, Elia Seguí, Juan Miguel Cejalvo, Mafalda Oliveira, Pablo Tolosa, Maria Vidal, Marcos Malumbres, Joaquín Gavilá, Cristina Saura, Sonia Pernas, Rafael López, Mireia Margelí, Judith Balmaña, Montserrat Muñoz, Isabel Blancas, Valentina Boni, Eva Ciruelos, Elena Galve, Antonia Perelló, Rodrigo Sánchez-Bayona, Susana de la Cruz, Miguel de la Hoya, Patricia Galván, Esther Sanfeliu, Blanca Gonzalez-Farre, Valeria Sirenko, Aura Blanch-Torras, Jordi Canes, Helena Masanas, Rosa Olmos, Margarita Forns, Aleix Prat, Ana Casas, Tomás Pascual
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundMetastatic breast cancer (mBC) causes nearly all BC-related deaths. Next-generation sequencing (NGS) technologies allow for the application of personalized medicine using targeted therapies that could improve patients’ outcomes. However,
Externí odkaz:
https://doaj.org/article/824e6c3277784295a0300733bf18032a
Autor:
Meritxell Bellet, Faten Ahmad, Rafael Villanueva, Carolina Valdivia, Julián Palomino-Doza, Ada Ruiz, Xavier Gonzàlez, Encarna Adrover, Analía Azaro, Maria Valls-Margarit, Josep Lluís Parra, Juan Aguilar, Maria Vidal, Anastasi Martín, Joaquín Gavilá, Santiago Escrivá-de-Romaní, Antonia Perelló, Cristina Hernando, Ainhara Lahuerta, Pilar Zamora, Victoria Reyes, María Alcalde, Helena Masanas, Pamela Céliz, Isabel Ruíz, Miguel Gil, Miguel Àngel Seguí, Lorena de la Peña
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Drug–drug interactions are of significant concern in clinical practice in oncology, particularly in patients receiving Cyclin-dependent kinase (CDK) 4/6 inhibitors, which are typically exposed to long-term regimens. This article presents the highli
Externí odkaz:
https://doaj.org/article/90c5d8caa4924ce685b690ebd1b8579b
Autor:
Ana Casas, Eva Ciruelos, Mafalda Oliveira, Cristina Saura, Meritxell Bellet, Sonia Pernas, Joaquín Gavilá, Montserrat Muñoz, Maria Vidal, Blanca González-Farré, Juan M. Cejalvo, Rafael López, Ana Vivancos, Marcos Malumbres, Javier Salvador Bofill, Isabel Blancas, Emilio Alba, Valentina Boni, Susana De la Cruz, Elena Galve, Antonia Perelló, Mireia Margelí, Meritxell Soler, Rubén Olivera-Salguero, Helena Masanas, Rosa Olmos, Marga Forns, Pilar Fernández Pascual, Elia Seguí, Tomas Pascual, Aleix Prat
Publikováno v:
Cancer Research. 82:OT2-06
BACKGROUND: Metastatic breast cancer (mBC) remains an incurable disease and is the cause of nearly all deaths related to BC. Next-generation sequencing technologies are allowing the application of personalized targeted molecular therapies, thereby im
Autor:
Cristina Saura, Montserrat Muñoz, Helena Masanas, Isabel Blancas, Ana Vivancos, Aleix Prat, Valentina Boni, Emilio Alba, Pamela Céliz, Joaquín Gavilá, Mafalda Oliveira, Juan Miguel Cejalvo, Rosa Olmos, Meritxell Bellet, Javier Salvador Bofill, Eva Ciruelos, Jordi Canes, Susana De la Cruz, Mireia Margeli, Antonia Perelló, Maria Vidal, Pilar Fernandez-Pascual, Sonia Pernas, Maurizio Scaltriti, Patricia Villagrasa, Ana M. Casas, Marga Fonts, Rafael López, Blanca González Farré, Elena Galve
Publikováno v:
Cancer Research. 81:OT-17
BACKGROUND: Metastatic breast cancer (mBC) remains an incurable disease and is the cause of nearly all deaths from breast cancer. Targeted molecular therapies and the evolving role of next-generation sequencing (NGS) technologies are increasing and m
Publikováno v:
Journal of Biological Methods, Vol 1, Iss 2, Pp e9-e9 (2014)
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Xenopus tadpoles are an emerging model for developmental, genetic and behavioral studies. A small size, optical accessibility of most of their organs, together with a close genetic and structural relationship to humans make them a convenient experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa7bf7d521236bcf09c028af7c0f64a
http://hdl.handle.net/2445/183193
http://hdl.handle.net/2445/183193
Autor:
Isabel Ruiz, Analia Azaro, Encarna Adrover, Xavier Gonzalez, Faten Ahmad, Ada I. Ruiz, Antonia Perelló, Cristina Hernando, Ainhara Lahuerta, Maria Valls-Margarit, Miguel Ángel Seguí, Carolina Valdivia, Pilar Zamora, Santiago Escrivá-de-Romaní, Rafael Villanueva, Pamela Céliz, Meritxell Bellet, Julián Palomino-Doza, Helena Masanas, V. Reyes, Maria Vidal, Joaquín Gavilá, María Soledad Gómez Alcalde, Josep Lluís Parra, Juan Aguilar, Anastasi Martín, Miguel Gil, Lorena de la Peña
Publikováno v:
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
Therapeutic Advances in Medical Oncology
Dipòsit Digital de la UB
Universidad de Barcelona
Biblos-e Archivo. Repositorio Institucional de la UAM
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
Therapeutic Advances in Medical Oncology
Dipòsit Digital de la UB
Universidad de Barcelona
Biblos-e Archivo. Repositorio Institucional de la UAM
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Drug-drug interactions are of significant concern in clinical practice in oncology, particularly in patients receiving Cyclin-dependent kinase (CDK) 4/6 inhibitors, which are typically exposed to long-term regimens. This article presents the highligh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18039a50e3b671cfcf3ffa1b7a64a31
http://hdl.handle.net/11351/4251
http://hdl.handle.net/11351/4251
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Olfactory sensory neurons (OSNs) are chemoreceptors that establish excitatory synapses within glomeruli of the olfactory bulb. OSNs undergo continuous turnover throughout life, causing the constant replacement of their synaptic contacts. Using Xenopu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c65289fec7ce97aeedca8be138f8665
http://hdl.handle.net/2445/147225
http://hdl.handle.net/2445/147225